logo

For the Inventor, By the Inventor

East Brunswick, NJ, United States of America

James A Mezick

This inventor holds 11 USPTO granted patents. Top assignees: Johnson & Johnson Gmbh, Ortho Pharmaceutical Corporation, Johnson & Johnson Consumer Companies, Inc.. Active years: 1978-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: James A Mezick. Retrieved from https://idiyas.com/inventor/james-a-mezick

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11

% Patents Active = 100.0

Average Co-Inventor Count = 2.4

ph-index = 8

Forward Citations = 213(Granted Patents)


Company Filing History:

goldMedal6 out of 511 
 
Johnson & Johnson Gmbh
 patents
silverMedal4 out of 377 
 
Ortho Pharmaceutical Corporation
 patents
bronzeMedal1 out of 271 
 
Johnson & Johnson Consumer Companies, Inc.
 patents

Years Active: 1978-2002

Loading Chart...
11 patents (USPTO):Explore Patents
1. 6488940 - Use of 17-&agr;-estradiol for the treatment of aged or sundamaged skin and/or skin atrophy (2002-12-03),
2. 5643584 - Aqueous gel retinoid dosage form (1997-07-01),
3. 5019569 - Reversal of glucocorticoid-induced skin atrophy (1991-05-28),
4. 4889847 - Prevention of glucocorticoid-induced skin atrophy (1989-12-26),
5. 4579844 - Topical anti-inflammatory drug therapy (1986-04-01),
6. 4487782 - Topical treatment of non-inflammatory acne (1984-12-11),
7. 4473565 - Topical anti-inflammatory drug therapy (1984-09-25),
8. 4360518 - Topical anti-inflammatory drug therapy (1982-11-23),
9. 4282216 - Topical anti-inflammatory drug therapy (1981-08-04),
10. 4185100 - Topical anti-inflammatory drug therapy (1980-01-22),
11. 4073291 - Topical device for administering tretinoin (1978-02-14),

Title: James A Mezick: Innovator in Dermatological Treatments

Introduction

James A Mezick is a notable inventor based in East Brunswick, NJ (US). He has made significant contributions to the field of dermatology, holding a total of 11 patents. His work primarily focuses on innovative treatments for skin conditions, showcasing his dedication to improving skin health.

Latest Patents

Among his latest patents, Mezick has developed a method for the treatment of aged or sun-damaged skin using 17-&agr;-estradiol. This invention relates to a method that stimulates connective tissue synthesis, providing a safe and effective treatment for skin in need. Another significant patent is for an aqueous gel retinoid dosage form. This invention utilizes micronized particles of retinoids, particularly tretinoin, to create an aqueous gel that minimizes skin irritation while maintaining drug efficacy.

Career Highlights

Throughout his career, James A Mezick has worked with prominent companies such as Johnson & Johnson GmbH and Ortho Pharmaceutical Corporation. His experience in these organizations has allowed him to develop and refine his innovative ideas in dermatological treatments.

Collaborations

Mezick has collaborated with notable individuals in his field, including John R Marvel and David T Rovee. These collaborations have contributed to the advancement of his research and inventions.

Conclusion

James A Mezick's contributions to dermatology through his patents and collaborations highlight his role as an influential inventor. His innovative approaches to skin treatment continue to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…